Evaluation of Laser in Situ Keratomileusis Outcomes in Cipto Mangunkusumo Hospital
Article Sidebar
October 24, 2015
October 24, 2015
Abstract
Background: The aim of this study is to evaluate the efficacy, predictability and safety of the first experience in laser in situ keratomileusis (LASIK) surgery using Wavelight Refractive Suite in Kirana Cipto Mangunkusumo Hospital
Methods: Design of this study was descriptive retrospective. Data of patients who underwent LASIK surgery from April 2012 to January 2013 were collected. The data consist of pre and post operative refractions, uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA).
Results: Fifty eight eyes of 31 patients, 13 males and 18 females, mean age of 28 year-old were analyzed. The mean spherical error corrected was -6,42 ± 3,37 D with range of -1.25 D to -16,87D. Median UCVA post surgery 1 day, 1 week, and last follow up time were 6/7,5, 6/6, and 6/6 respectively. Postoperatively, 91,67% eyes achieved UCVA of 6/12 or better with 77,78% achieving 6/7,5 or better. One patient lost 1 Snellen line of BCVA became 6/6,6. The mean postoperative manifest refraction spherical equivalent was -0,24 (±0,42) D. The general refractive predictability was 88,2% within ±0.5D from the target refraction, while 94,1% within ±1D ofthetarget.
Conclusion: LASIK surgery performed in Kirana Cipto Mangunkusumo Hospital is safe and effective with good refractive predictability.
References
American Academy of Ophthalmology Staff. In: Refractive surgery, basic and clinical course. Section 13. San Fransisco: American Academy of Ophthalmology; 2009 - 2010. p. 41-58, 89-147
American Academy of Ophthalmology. Refractive Surgery: an in- depth look at LASIK. http://www.aao.org/newsroom/guide/upload/ LASER_Surg_LASIK_SWGuideNewsroom.pdf
Melki SA, Azar DT. LASIK Complication: Etiology, Management, and Prevention. Surv of Ophthalmol. 2001:46;95-116
Farjo AA, Sugar A, Scallhorn SC, Majmudar PA, Tanzer DJ, Trattler WB, et al. Femtosecond Laser for LASIK Flap Creation. Ophthalmol. 2012. In prees corrected proof.
Solomon KD, Fernandez de Castro LE, Sandoval HP, Biber JM, Groat B, Neff KD, et al. LASIK World Literature Review Quality of Life and Patient Satisfaction. Ophthalmology. 2009;116:691–701
Kymionis GD, Tsiklis NS, Astyrakakis N, Pallikaris AI, Panagopoulou SI, Pallikaris IG. Eleven-year Follow-up of Laser insitu Keratomileusis. J Cataract Refract Surg. 2007;33: 191-196
Patel SV, Maguire LJ, McLaren JW, Hodg DO, Bourne WM. Femtosecond Laser versus Mechanical Microkeratom for LASIK. Ophthalmology 2007;114:1482–1490
Guzman CP, Abano JMR. Wavefront-optimized treatment for myopia using Allegreto Wave Eye-Q excimer laser. Philipp J Ophthalmol.2011; 36;38-41
Bailey MD, Zadnik K. Outcome of LASIK for Myopia with FDA- Approved Lasers. Cornea 2007;26:246–254
Kymionis GD, Tsiklis NS, Astyrakakis N, Pallikaris AI, Panagopoulou SI, Pallikaris IG. Eleven-year Follow-up of Laser insitu Keratomileusis. J Cataract Refract Surg. 2007;33: 191-196
Yuen LH, Chan WK, Koh J, Mehta JS, Tan DT. A 10-Year Prospective Audit of LASIK Outcomes for Myopia i 37,932 Eyes at A Single Institution in Asia. Ophthalmology. 2010; 117(6):1236- 1244.
The United States Food and Drug Administration. Center for Devices and Radiological Health. LASIK. ttp://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/SurgeryandLifeSupport/LASIK/default.htm
Albelda-Valles JC, Martin-Reyes C, Ramos F, Beltran J, Llovet F, Baviera J. Effect of Preoperative Keratometric Power n Intraoperative Complications in LASIK in 34.099 Eyes. J Refract Surg. 2007;23:592-597
Maldonado-Bas A, Onnis R. Results of Laser In Situ Keratomileusis in Different Degrees of Myopia. Ophthalmology 1998; 705:606-67 7
Stonecipher KG, Kezirian GM. Wavefront-optimized Versus wavefrontguided LASIK for Myopic Astigmatism With the ALLEGRETTO WAVE: Three-month Results of a Prospective FDA Trial. J Refract Surg. 2008;24:S424-S430.
Schallhorn SC, Amesbury EC, Tanzer DJ. Avoidance, Recognition, and Management of LASIK Complications. Am J Ophthalmol. 2006;141:733–739
